These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7460836)

  • 41. A possible role for prolactin in the control of human chorionic gonadotropin and estrogen secretion by the fetoplacental unit.
    Ho Yuen B; Cannon W; Lewis J; Sy L; Woolley S
    Am J Obstet Gynecol; 1980 Feb; 136(3):286-91. PubMed ID: 7352519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histamine concentrations in normal and cystic rat ovaries.
    Hunter F; Leathem JH
    Endocrinology; 1968 Jan; 82(1):171-2. PubMed ID: 5688717
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of inhibitory effect of exogenous prolactin on ovarian responsiveness to gonadotropins in the rat.
    Kawagoe S; Hiroi M
    Endocrinol Jpn; 1983 Feb; 30(1):127-31. PubMed ID: 6884271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mode of action of chlorpromazine (CPZ) blockage on 13,14-dihydroprostaglandin F2-alpha formation in rat ovary.
    Kogo H; Iida H; Taya K; Sasamoto S; Inazu N; Satoh T
    Prostaglandins Leukot Med; 1987 Oct; 29(2-3):153-63. PubMed ID: 3432304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of cystic ovary induction in rabbits by aminoglutethimide.
    Albrecht E
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):242-5. PubMed ID: 6932152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical and histological evidence of thyroid gland dysfunction in estradiol valerate model of the polycystic ovary in Wistar rats.
    Alzahrani AA; Alahmadi AA; Ali SS; Alahmadi BA; Arab RA; Wahman LF; El-Shitany NA
    Biochem Biophys Res Commun; 2019 Jun; 514(1):194-199. PubMed ID: 31029417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretory dynamics of bioactive and immunoreactive prolactin in polycystic ovary syndrome.
    Anderson RE; Ben-Rafael Z; Flickinger GL; Meloni F; Barnes RB; Rosen GF; Lobo RA
    Fertil Steril; 1988 Feb; 49(2):239-43. PubMed ID: 3276562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of transient hyperprolactinemia in the late follicular phase of the gonadotropin-stimulated cycle.
    Takiguchi S; Nakamura Y; Yamagata Y; Takayama H; Harada A; Sugino N; Kato H
    Reprod Med Biol; 2002 Sep; 1(2):69-74. PubMed ID: 29662350
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolic profiles of prostate gland after the administration of prolactin and bromocriptine.
    Dhananjaya Reddy Y; Venkatarami Reddy K; Govindappa S
    Arch Int Physiol Biochim; 1984 Aug; 92(2):125-30. PubMed ID: 6208863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovarian hyperstimulation in rats.
    Lindenbaum ES; Bar Sela P; Itzkovitz J; Beach D; Brandeis J
    Eur J Obstet Gynecol Reprod Biol; 1980 Sep; 11(1):57-67. PubMed ID: 7193611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Physiopathology of the secretion of prolactin in ovarian polycystosis].
    Falaschi P; Rosa M; Proietti A; Di Cesare G; Canfalone GC
    Minerva Endocrinol; 1987; 12(3):195-8. PubMed ID: 2821372
    [No Abstract]   [Full Text] [Related]  

  • 52. Ovarian gonadotropin receptors during experimental ovarian cyst formation in the rat.
    Copmann TL; Adams WC
    Biol Reprod; 1981 Aug; 25(1):115-9. PubMed ID: 6269663
    [No Abstract]   [Full Text] [Related]  

  • 53. Reduction of body fat stores by inhibition of prolactin secretion.
    Cincotta AH; Meier AH
    Experientia; 1987 Apr; 43(4):416-7. PubMed ID: 3569491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PROTEINS OF OVARIAN CYST FLUID AND SERUM FROM HYPOTHYROID GONADOTROPHIN-TREATED RATS.
    YATVIN MB
    Proc Soc Exp Biol Med; 1963; 113():809-12. PubMed ID: 14073110
    [No Abstract]   [Full Text] [Related]  

  • 55. Lack of effect of bromocriptine on serum levels of calcium in the rat.
    Tan CM; Tan GJ
    Clin Exp Pharmacol Physiol; 1978; 5(5):541-3. PubMed ID: 729210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine agonists for polycystic ovary disease?
    González ER
    JAMA; 1982 Aug; 248(5):514. PubMed ID: 7097888
    [No Abstract]   [Full Text] [Related]  

  • 57. Significance of prolactin in spontaneously persistent oestrous rats.
    Gosden RG
    J Endocrinol; 1978 Sep; 78(3):451-2. PubMed ID: 568649
    [No Abstract]   [Full Text] [Related]  

  • 58. Uptake of P32 by the cystic ovary of the rat.
    HOPPER AF
    Endocrinology; 1962 Nov; 71():740-4. PubMed ID: 13961697
    [No Abstract]   [Full Text] [Related]  

  • 59. Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome.
    Krysiak R; Kowalcze K; Szkróbka W; Okopień B
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of polycystic ovary induction to prolactin secretion: prevention of cyst formation by bromocriptine in the rat.
    Copmann TL; Adams WC
    Endocrinology; 1981 Mar; 108(3):1095-7. PubMed ID: 7460836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.